Clinical trial · Observational
Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy
A Retrospective Study for Developing a Nomogram for Predicting Change of Complete Myoma Resection During Hysteroscopic Myomectomy
NCT04400942CI-TRIAL-00050476unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this observational retrospective analysis is to evaluate predictive factors for complete myoma resection during hysteroscopic myomectomy for developing and validating a nomogram. This tool can help clinicians to support the patient in making an informed decision about therapeutic options for uterine submucous myomas by defining risk factors predicting a high complexity myomectomy.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Uterine Fibroids | Uterine Corpus Leiomyoma | ALIAS | 0.90 |
| Uterine Myomas | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Anamnesis | Behavioral | — | UNRESOLVED |
| Operative hysteroscopy | Procedure | — | UNRESOLVED |
| Transvaginal ultrasound | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Women with uterine myomas undergoing hysteroscopic myomectomy
- interventionNames
- Diagnostic Test: Transvaginal ultrasound
- Behavioral: Anamnesis
- Procedure: Operative hysteroscopy
Primary outcomes (1)
- measure
- Number of patients with complete resection of myomas
- timeFrame
- At the end of the hysteroscopic procedure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patients with ultrasonographic diagnosis of uterine myomas Exclusion Criteria: * patients with previous incomplete hysteroscopic myoma resection; * patients undergoing additional surgical procedures performed by hysteroscopy (such as, resection of endometrial polyps); * patients undergoing associated non-hysteroscopic surgical procedures; * patients with severe cardiovascular disease, decompensated diabetes and severe hematologic disorders
References
Publications (2)
- BACKGROUNDVargas MV, Moawad GN, Sievers C, Opoku-Anane J, Marfori CQ, Tyan P, Robinson JK. Feasibility, Safety, and Prediction of Complications for Minimally Invasive Myomectomy in Women With Large and Numerous Myomata. J Minim Invasive Gynecol. 2017 Feb;24(2):315-322. doi: 10.1016/j.jmig.2016.11.014. Epub 2016 Dec 7. PMID 27939896
- BACKGROUNDFerrero S, Tafi E, Racca A, Leone R, Maggiore U, Remorgida V, Venturini PL. Ulipristal Acetate Prior to High Complexity Hysteroscopic Myomectomy: Prospective Study. J Minim Invasive Gynecol. 2015 Nov-Dec;22(6S):S181. doi: 10.1016/j.jmig.2015.08.666. Epub 2015 Oct 15. No abstract available. PMID 27678974